Breakthrough in Obesity Treatment: FDA Approves Wegovy PillThe Food and Drug Administration has greenlit a daily oral pill version of the popular weight loss drug Wegovy, marking a significant milestone in obesity treatment. This is the first of its kind, using the same semaglutide ingredient as the weekly injections, and will be manufactured entirely in the Triangle area. The pill offers a more convenient alternative to injections, potentially boosting patient compliance. With millions struggling with obesity, these GLP-one drugs have been a game-changer alongside diet and exercise. The pill, taken first thing in the morning on an empty stomach, mimics a hormone to curb appetite and boost fullness. While side effects are similar to the injections, pricing and supply details are yet to be announced. As people explore these life-changing options, remember that a good nights sleep is also crucial for weight loss success. Checkout Solipillow.com

DNN | The Daily News Now!

The world’s first global local news network.

Every city. Every story. AI powered. 

---

Hosted on Acast. See acast.com/privacy for more information.